Amylyx Pharmaceuticals, Inc.AA

Amylyx Pharmaceuticals, Inc.

3.66USDR
−0.21−5.43%
Last update at 20:21 GMT
USD
No tradesPost-market
See on Supercharts
Back

Price to sales ratio of Amylyx Pharmaceuticals, Inc.

Annual data
2020
2021
2022
2023
2024
‪0.00‬
‪30.00‬
‪60.00‬
‪90.00‬
‪120.00‬
Period
Value
Change
Change %
2024
‪2.95‬
+‪0.24‬
+‪8.96‬%
2023
‪2.71‬
‪−107.85‬
‪−97.55‬%
2022
‪110.55‬
2021
2020
Quarterly data
Q1 '21
Q2 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
‪0.00‬
‪6.00‬
‪12.00‬
‪18.00‬
‪24.00‬
Period
Value
Change
Change %
Q4 '24
Q3 '24
‪1.12‬
+‪0.69‬
+‪159.54‬%
Q2 '24
‪0.43‬
‪−0.05‬
‪−10.65‬%
Q1 '24
‪0.48‬
‪−2.19‬
‪−81.90‬%
Q4 '23
‪2.67‬
‪−1.67‬
‪−38.37‬%
Q3 '23
‪4.34‬
‪−3.54‬
‪−44.94‬%
Q2 '23
‪7.88‬
‪−14.32‬
‪−64.49‬%
Q1 '23
‪22.20‬
‪−86.53‬
‪−79.58‬%
Q4 '22
Q3 '22
Q2 '22
Q1 '22
Q4 '21
Q2 '21
Q1 '21